Assessing the effectiveness of a mammography screening service

ANZ Journal of Surgery

Volumn 75, Issue 8, 2005, Pages 631-636

  Clayforth, Cassandra ^a   Fritschi, Lin ^a   McEvoy, Suzanne ^a   Byrne, Michael J ^b   Wylie, Elizabeth ^c   Threlfall, Tim ^d   Sterrett, Greg ^a,e   Harvey, Jennet M ^a,e   Jamrozik, Konrad ^f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c BreastScreen WA   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e PathCentre   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast neoplasm; Mammography; Mass screening; Programme evaluation

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LOCAL THERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; MORBIDITY; SYSTEMIC THERAPY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CARCINOMA IN SITU; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGRAM EVALUATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 27844517168     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2005.03476.x     Document Type: Article

References (32)

1. Australian Institute of Health and Welfare. National Health Priority Areas - Cancer Indicators. Canberra: AIHW, 2003.
2. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 129-34.
3. Solin LJ, Legorreta A, Schultz DJ et al. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. Arch. Intern. Med. 1994; 154: 745-52.
4. BreastScreen WA. 1998-1999 Statistical Report. Perth: Breast-Screen WA, 2001.
5. Langlands A. The next 100 years - prognostic factors, screening and prevention. Breast News 1996; 2: 5.
6. Fitzgibbons PL, Page DL, Weaver D et al. Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999. Arch. Pathol. Lab. Med. 2000; 124: 966-78.
7. Tabar L, Fagerberg G, Duffy SW et al. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol. Clin. North Am. 1992; 30: 187-210.
8. National Breast Cancer Centre. Clinical Practice Guidelines: Management of Early Breast Cancer, 2nd edn. Canberra: Commonwealth of Australia, 2001.
9. McEvoy SP, Ingram DM, Byrne MJ et al. Breast cancer in Western Australia: clinical practice and clinical guidelines. Med. J. Aust. 2004; 181: 305-9.
10. Jamrozik K, Byrne MJ, Dewar JM et al. The effect of mammographic screening on invasive breast cancer in Western Australia. Med. J. Aust. 2000; 172: 203-6.
11. Klemi PJ, Joensuu H, Toikkanen S et al. Aggressiveness of breast cancers found with and without screening. Br. Med. J. 1992; 304: 467-9.
12. Ernst MF, Roukema JA, Coebergh JW et al. Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res. Treat 2002; 76: 19-25.
13. Feig SA. Methods to identify benefit from mammographic screening of women aged 40-49 years. Radiology 1996; 201: 309-16.
14. Cowan WK, Kelly P, Sawan A et al. The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J. Pathol. 1997; 182: 29-35.
15. Hakama M, Holli K, Isola J et al. Aggressiveness of screen-detected breast cancers. Lancet 1995; 345: 221-4.
16. Moody C, Corder A, Mullee MA et al. The impact of the first 3 years of breast cancer screening on the overall presentation of breast cancer. J. R. Soc. Med. 1994; 87: 259-62.
17. Chen WY, Hankinson SE, Schnitt SJ et al. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 2004; 101: 1490-500.
18. Tjonneland A, Christensen J, Thomsen BL et al. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 2004; 100: 2328-37.
19. Gajdos C, Tartter PI, Babinszki A. Breast cancer diagnosed during hormone replacement therapy. Obstet Gynecol. 2000; 95: 513-18.
20. Kerlikowske K, Grady D, Rubin SM et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995; 273: 149-54.
21. Lower EE, Blau R, Gazder P et al. The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Breast Cancer Res. Treat 1999; 58: 205-11.
22. Ursin G, Tseng CC, Paganini-Hill A et al. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J. Clin. Oncol. 2002; 20: 699-706.
23. Li CI, Malone KE, Porter PL et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003; 289: 3254-63.
24. Cheek J, Lacy J, Toth-Fejel S et al. The impact of hormone replacement therapy on the detection and stage of breast cancer. Arch. Surg. 2002; 137: 1015-19.
25. Holli K, Isola J, Cuzick J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J. Clin. Oncol. 1998; 16: 3115-20.
26. O'Meara ES, Rossing MA, Daling JR et al. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J. Natl Cancer Inst. 2001; 93: 754-62.
27. Bonnier P, Bessenay F, Sasco AJ et al. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer. Int. J. Cancer 1998; 79: 278-82.
28. Delgado RC, Lubian Lopez DM. Prognosis of breast cancers detected in women receiving hormone replacement therapy. Maturitas 2001; 38: 147-56.
29. Esteve J, Seradour B, Jacquemier J et al. Does a better grade of tumour occurring in women under hormone replacement therapy compensate for their lower probability of detection by screening mammography. J. Med. Screen 2002; 9: 70-3.
30. Olivotto IA, Mates D, Kan L et al. Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Res. Treat 1999; 54: 73-81.
31. Crawford MD, Biankin AV, Rickard MT et al. The operative management of screen-detected breast cancers. Aust. N. Z. J. Surg. 2000; 70: 168-73.
32. Australian Institute of Health and Welfare. Breast Cancer Size and Nodal Status. Canberra: AIHW, 2001.